AMRX - Latest News

Amneal Pharmaceuticals, Inc. (AMRX), operates in Healthcare / Drug Manufacturers - Specialty & Generic, trades on NASDAQ.

Market capitalization stands near $3.95B. Trailing twelve-month P/E ratio is 33.31. Beta to the broader market is 1.32.

The article list below shows the most recent AMRX headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.

Recent AMRX Headlines

3 Reasons Why Growth Investors Shouldn't Overlook Amneal (AMRX)

zacks.com - May 15, 2026

Amneal (AMRX) is well positioned to outperform the market, as it exhibits above-average growth in financials.

Should Value Investors Buy Amneal Pharmaceuticals (AMRX) Stock?

zacks.com - May 15, 2026

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Neverth

Amneal (AMRX) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates (Revised)

zacks.com - May 8, 2026

Although the revenue and EPS for Amneal (AMRX) give a sense of how its business performed in the quarter ended March 2026, it might be worth consideri

Amneal Reports First Quarter 2026 Financial Results

globenewswire.com - May 7, 2026

‒  Q1 2026 Net Revenue of $723 million ; GAAP Net Income of $62 million ; Diluted Income per Share of $0. 19 ‒ ‒ Adjusted EBITDA of $202 million ; Adj

Is Amneal (AMRX) a Solid Growth Stock? 3 Reasons to Think "Yes"

zacks.com - Apr 29, 2026

Amneal (AMRX) is well positioned to outperform the market, as it exhibits above-average growth in financials.

How News Affects AMRX Options Pricing

Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track AMRX's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.

Frequently asked AMRX news questions

What is the latest AMRX news headline?

The most recent AMRX headline (May 15, 2026) is "3 Reasons Why Growth Investors Shouldn't Overlook Amneal (AMRX)". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.

How fresh is the AMRX news on this page?

News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.

What AMRX news moves options pricing?

Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.

How can I track unusual AMRX options activity related to news?

Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.